ESC 365 - The developing case for using baroreflex activation therapy in HFrEF.

HFA Premium Access

The developing case for using baroreflex activation therapy in HFrEF.

Session: Baroreflex activation therapy in Heart Failure with reduced Ejection Fraction (HFrEF): overcoming the limits of currently available therapies

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Speaker: Professor J. Bauersachs (Hannover, DE)

Sponsored by Charité Berlin

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Johann Bauersachs

Hannover Medical School, Hannover (Germany)

50 presentations

12 followers

3 more presentations in this session

Welcome and introduction - Baroreflex activation therapy in Heart Failure with reduced Ejection Fraction (HFrEF): overcoming the limits of currently available therapies.

Speaker: Professor S. Anker (Berlin, DE) Professor G. Filippatos (Athens, GR)

Why do we need new therapies for patients with HFrEF?

Speaker: Professor B. Merkely (Budapest, HU)

Review of new approaches to the management of HFrEF.

Speaker: Doctor E. Gronda (Sesto S. Giovanni, IT)

Access the full session

Baroreflex activation therapy in Heart Failure with reduced Ejection Fraction (HFrEF): overcoming the limits of currently available therapies

Speakers: Professor J. Bauersachs, Professor S. Anker, Professor G. Filippatos, Professor B. Merkely, Doctor E. Gronda

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources